Fig. 2From: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO studyDot histogram showing the mean cell survival of each tumor sample following cytostatic treatment in the breast cancer spheroid model. The results are grouped according to pCR. Each dot represents one patient; triangles represent patients treated with trastuzumab-based therapy. Proposed cutoff to predict pCR is shown at 35 % cell survivalBack to article page